MedTrace Logo

Effects of an Air Purifying Device (PureNight) on Sleep Quality in Obstructive Lung Disease

NCT01772342 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2013-01-24

No results posted yet for this study

Summary

Many individuals with chronic lung disease have night time symptoms that disrupt their sleep. The purpose of this study is to determine the effects of an air purifying device (PureNight, Halo Innovations, Minneapolis, MN) on sleep disruptions measured by a "sleep watch" (actigraph) and individual perception of sleep quality.

Conditions

Interventions

OTHER

HEPA filtration

Night time air purification with the PureNight air purification system with the HEPA filter in place

OTHER

SHAM

Night time air purification with the PureNight air purification system with the HEPA filter removed

Sponsors & Collaborators

  • VA New York Harbor Healthcare System

    lead FED

Principal Investigators

  • Miriam D Cohen · VA, NYHH

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
35 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-03-31
Primary Completion
2011-11-30
Completion
2011-11-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01772342 on ClinicalTrials.gov